Aptose Biosciences (TSE:APS)
TSX:APS
Holding TSE:APS?
Track your performance easily

Aptose Biosciences (APS) Cash flow

130 Followers

Aptose Biosciences Cash Flow

TSE:APS's free cash flow for Q2 2024 was $-5.76M. For the 2024 fiscal year, TSE:APS's free cash flow was decreased by $-12.27M and operating cash flow was $-5.78M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -37.34M$ -44.59M$ -32.32M$ -43.30M$ -33.89M$ -21.56M
Investing Cash Flow
$ 14.91M$ 9.96M$ 30.07M$ -35.21M$ 12.63M$ -17.37M
Financing Cash Flow
$ 22.36M$ 6.91M$ 116.00K$ 226.00K$ 58.81M$ 103.45M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 40.64M$ 9.25M$ 36.97M$ 39.11M$ 117.39M$ 79.84M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 22.53M$ 6.91M$ 101.00K$ 36.00K$ 58.40M$ 93.17M
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ -37.32M$ -44.62M$ -32.35M$ -43.30M$ -33.89M$ -21.56M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Aptose Biosciences Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis